Skip to Main Content

Richard Schottenfeld, MD

Senior Research Scientist

Contact Information

Richard Schottenfeld, MD

Mailing Address

  • Psychiatry

    300 George St

    New Haven, CT, 06511-

    United States

Richard Schottenfeld
DownloadHi-Res Photo

Appointments

Biography

Dr Schottenfeld is an experienced clinician, teacher and
clinical researcher who has focused on improving the efficacy, accessibility
and availability of addictions treatment in the United
States and internationally (in Malaysia,
Iran and China.) In clinical trials and clinical epidemiologic
studies, he has developed new programs that integrate addictions treatment and
general medical services and has evaluated the pharmacological and behavioral
components of different treatments for opioid dependence and other addictive
disorders. In his clinical, administrative and teaching roles, he oversaw
development of a multi-component drug abuse treatment program providing
innovative ambulatory and residential treatment for addictive disorders and was
the founding Director of the Addiction Psychiatry Residency Training Program
and the drug abuse clinical research post-doctoral training program at Yale.

Education & Training

  • MD
    Yale University (1976)

Activities

  • Malaysia, Iran, HIV, Drug abuse, Opioid, Cocaine
    Malaysia 2010
    Improving Efficacy of Drug Abuse Treatment
  • Malaysia, Heroin, HIV
    Malaysia 2010
    Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
  • Opioid dependence
    Wuhan, China (2007-2014)
    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.
  • Opioid dependence
    Tehran, Iran (2003-2012)
    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.
  • Opioid Dependence
    Muar, Malaysia (2001-2014)
    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.

Honors & Recognition

AwardAwarding OrganizationDate
Nyswander-Dole AwardAmerican Association for the Treatment of Opioid Dependence2004

Departments & Organizations